# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $50 price t...
JP Morgan analyst Eric Joseph maintains Biomea Fusion (NASDAQ:BMEA) with a Neutral and raises the price target from $14 to $15.
Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.9...
Oppenheimer analyst Hartaj Singh maintains Biomea Fusion (NASDAQ:BMEA) with a Outperform and maintains $70 price target.
JP Morgan analyst Gavin Scott downgrades Biomea Fusion (NASDAQ:BMEA) from Overweight to Neutral and lowers the price target ...
HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $50 price t...
Truist Securities analyst Robyn Karnauskas reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $55 price target.
Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.8...